Evaluation The effect of Selenium on Reducing Kidney Damage Following Cisplatin intake

Phase 2

Recruiting

• Conditions: In this study, patients admitted to the hematology ward selected by physician for cisplatin injection are studied. The primary type of disease can include testicular tumors, head and neck tumors, cervical cancer, lung cancer, and tumor germ germ..; Nephropathy induced by other drugs, medicaments and biological substances; N14.1

• Registration Number: IRCT20201116049407N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Absence of kidney disease and any kidney failure
Do not take other nephrotoxic drugs such as nephrotoxic antibiotics
indications for taking cisplatin to the patient

Exclusion Criteria

starting nephrotoxic drug is for the patient during treatment
Reducing of the patient to continue cooperation
Acute and chronic renal failure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
rine level of KIM-1. Timepoint: At the beginning of treatment, and two days after the end of the treatment period. Method of measurement: The assay immunosorbent linked-enzyme (ELISA).